Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Jun 2018 | Jun 2017 | ||
---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||
Cost of Revenue | |||||||||
Gross Profit | |||||||||
Gross Profit Margin (%) | |||||||||
R&D Expense | |||||||||
SG&A Expense | |||||||||
Total Operating Expenses | |||||||||
Operating Income or Loss | |||||||||
Operating Margin (%) | |||||||||
Interest Expense | |||||||||
Total Other Income/Expenses | |||||||||
Income Before Tax | |||||||||
Income Tax Expense | |||||||||
Income from Continuing Ops. | |||||||||
Net Income | |||||||||
Net Profit Margin (%) | |||||||||
Net Income Available to Common Shareholders | |||||||||
Basic EPS | |||||||||
Diluted EPS | |||||||||
Basic Average Shares | |||||||||
Diluted Average Shares |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Jan 2017 | Oct 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | ||||||||||||||||
Cost of Revenue | ||||||||||||||||
Gross Profit | ||||||||||||||||
Gross Profit Margin (%) | ||||||||||||||||
R&D Expense | ||||||||||||||||
SG&A Expense | ||||||||||||||||
Total Operating Expenses | ||||||||||||||||
Operating Income or Loss | ||||||||||||||||
Operating Margin (%) | ||||||||||||||||
Interest Expense | ||||||||||||||||
Total Other Income/Expenses | ||||||||||||||||
Income Before Tax | ||||||||||||||||
Income Tax Expense | ||||||||||||||||
Income from Continuing Ops. | ||||||||||||||||
Net Income | ||||||||||||||||
Net Profit Margin (%) | ||||||||||||||||
Net Income Available to Common Shareholders | ||||||||||||||||
Basic EPS | ||||||||||||||||
Diluted EPS | ||||||||||||||||
Basic Average Shares | ||||||||||||||||
Diluted Average Shares |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Jun 2018 | Jun 2017 | ||
---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||
Cash & Cash Equivalents | |||||||||
Marketable Securities | |||||||||
Receivables | |||||||||
Inventories | |||||||||
Other Current Assets | |||||||||
Total Current Assets | |||||||||
Non-Current Assets | |||||||||
Marketable Securities | |||||||||
PPE Net | |||||||||
Intangibles inc. Goodwill | |||||||||
Other Non-Current Assets | |||||||||
Total Non-Current Assets | |||||||||
Total Assets | |||||||||
Current Liabilities | |||||||||
Accounts Payable | |||||||||
Deferred Revenues | |||||||||
Debt, Current | |||||||||
Accrued Liabilities | |||||||||
Other Current Liabilities | |||||||||
Total Current Liabilities | |||||||||
Non-Current Liabilities | |||||||||
Deferred Revenues | |||||||||
Debt, Non-Current | |||||||||
Other Non-Current Liabilities | |||||||||
Total Non-Current Liabilities | |||||||||
Total Liabilities | |||||||||
Shareholders' Equity | |||||||||
Common Stock | |||||||||
Additional Paid-In Capital | |||||||||
Retained Earnings | |||||||||
Other Shareholders' Equity | |||||||||
Total Shareholders' Equity | |||||||||
Total Liabilities & Shareholders' Equity |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Jan 2017 | Oct 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | ||||||||||||||||
Cash & Cash Equivalents | ||||||||||||||||
Marketable Securities | ||||||||||||||||
Receivables | ||||||||||||||||
Inventories | ||||||||||||||||
Other Current Assets | ||||||||||||||||
Total Current Assets | ||||||||||||||||
Non-Current Assets | ||||||||||||||||
Marketable Securities | ||||||||||||||||
PPE Net | ||||||||||||||||
Intangibles inc. Goodwill | ||||||||||||||||
Other Non-Current Assets | ||||||||||||||||
Total Non-Current Assets | ||||||||||||||||
Total Assets | ||||||||||||||||
Current Liabilities | ||||||||||||||||
Accounts Payable | ||||||||||||||||
Deferred Revenues | ||||||||||||||||
Debt, Current | ||||||||||||||||
Accrued Liabilities | ||||||||||||||||
Other Current Liabilities | ||||||||||||||||
Total Current Liabilities | ||||||||||||||||
Non-Current Liabilities | ||||||||||||||||
Deferred Revenues | ||||||||||||||||
Debt, Non-Current | ||||||||||||||||
Other Non-Current Liabilities | ||||||||||||||||
Total Non-Current Liabilities | ||||||||||||||||
Total Liabilities | ||||||||||||||||
Shareholders' Equity | ||||||||||||||||
Common Stock | ||||||||||||||||
Additional Paid-In Capital | ||||||||||||||||
Retained Earnings | ||||||||||||||||
Other Shareholders' Equity | ||||||||||||||||
Total Shareholders' Equity | ||||||||||||||||
Total Liabilities & Shareholders' Equity |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Jun 2018 | Jun 2017 | ||
---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||
Net Income | |||||||||
Depreciation & Amortization | |||||||||
Deferred Income Taxes | |||||||||
Stock Based Compensation | |||||||||
Accounts Receivable | |||||||||
Inventory | |||||||||
Accounts Payable | |||||||||
Deferred Revenue | |||||||||
Other Non-Cash | |||||||||
Operating Cash Flow | |||||||||
Cash Flows from Investing Activities | |||||||||
PPE Investments | |||||||||
Net Acquisitions | |||||||||
Purchase of Investments | |||||||||
Sale of Investments | |||||||||
Other Investing Activity | |||||||||
Investing Cash Flow | |||||||||
Cash Flows from Financing Activities | |||||||||
Debt Issued | |||||||||
Proceeds from Debt Repayment | |||||||||
Debt Repayment | |||||||||
Proceeds from Sale of Equity | |||||||||
Equity Repurchased | |||||||||
Dividend Paid | |||||||||
Other Financing Activity | |||||||||
Financing Cash Flow | |||||||||
Cash Position | |||||||||
Beginning Cash Position | |||||||||
End Cash Position | |||||||||
Change in Cash | |||||||||
Free Cash Flow | |||||||||
Operating Cash Flow | |||||||||
Capital Expenditure | |||||||||
Free Cash Flow |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Sep 2018 | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Jan 2017 | Oct 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | ||||||||||||||||
Net Income | ||||||||||||||||
Depreciation & Amortization | ||||||||||||||||
Deferred Income Taxes | ||||||||||||||||
Stock Based Compensation | ||||||||||||||||
Accounts Receivable | ||||||||||||||||
Inventory | ||||||||||||||||
Accounts Payable | ||||||||||||||||
Deferred Revenue | ||||||||||||||||
Other Non-Cash | ||||||||||||||||
Operating Cash Flow | ||||||||||||||||
Cash Flows from Investing Activities | ||||||||||||||||
PPE Investments | ||||||||||||||||
Net Acquisitions | ||||||||||||||||
Purchase of Investments | ||||||||||||||||
Sale of Investments | ||||||||||||||||
Other Investing Activity | ||||||||||||||||
Investing Cash Flow | ||||||||||||||||
Cash Flows from Financing Activities | ||||||||||||||||
Debt Issued | ||||||||||||||||
Proceeds from Debt Repayment | ||||||||||||||||
Debt Repayment | ||||||||||||||||
Proceeds from Sale of Equity | ||||||||||||||||
Equity Repurchased | ||||||||||||||||
Dividend Paid | ||||||||||||||||
Other Financing Activity | ||||||||||||||||
Financing Cash Flow | ||||||||||||||||
Cash Position | ||||||||||||||||
Beginning Cash Position | ||||||||||||||||
End Cash Position | ||||||||||||||||
Change in Cash | ||||||||||||||||
Free Cash Flow | ||||||||||||||||
Operating Cash Flow | ||||||||||||||||
Capital Expenditure | ||||||||||||||||
Free Cash Flow |